Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS CoV-2 Vaccination. Charilaou P, Tricarico C, Battat R, Scherl EJ, et al. Clin Gastroenterol Hepatol 2021 Dec 8. pii: S1542-3565(21)01301.

Read + Share

Amedeo Smart

Independent Medical Education

Charilaou P, Tricarico C, Battat R, Scherl EJ, et al. Impact of Inflammatory Bowel Disease Therapies on Durability of Humoral Response to SARS CoV-2 Vaccination. Clin Gastroenterol Hepatol 2021 Dec 8. pii: S1542-3565(21)01301.
PMID: 34896283